For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Scope of the Report:
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Viral Vectors and Plasmid DNA Manufacturing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Viral Vectors and Plasmid DNA Manufacturing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Cobra Biologics
- Oxford BioMedica
- FUJIFILM Diosynth Biotechnologies
- Cell and Gene Therapy Catapult
- Brammer Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Plasmid DNA
- Viral Vectors
Market Segment by Applications, can be divided into
- Inherited Disorders
- Viral Infections